 | Cardiff Oncology (NASDAQ:CRDF) Stock Price Up 5.9% americanbankingnews.com - March 5 at 7:52 PM |
 | Gary W. Pace Acquires 1,500 Shares of Cardiff Oncology, Inc. (NASDAQ:CRDF) Stock americanbankingnews.com - March 4 at 9:56 PM |
 | Cardiff Oncology (NASDAQ:CRDF) Trading Down 8.9% americanbankingnews.com - March 3 at 8:46 PM |
 | Cardiff Oncology to Present at H.C. Wainwright Global Life Sciences Conference finance.yahoo.com - March 3 at 8:45 AM |
 | Could The Cardiff Oncology, Inc. (NASDAQ:CRDF) Ownership Structure Tell Us Something Useful? finance.yahoo.com - February 27 at 9:52 AM |
 | Cardiff Oncology (NASDAQ:CRDF) Stock Price Up 6.1% americanbankingnews.com - February 26 at 7:19 PM |
 | Cardiff Oncology (NASDAQ:CRDF) Announces Earnings Results, Misses Expectations By $0.05 EPS americanbankingnews.com - February 26 at 1:46 PM |
 | Cardiff Oncology Announces Fourth Quarter and Full Year 2020 Results and Recent Highlights finance.yahoo.com - February 25 at 7:40 PM |
 | Cardiff Oncology (NASDAQ:CRDF) Stock Price Down 5.2% americanbankingnews.com - February 25 at 7:16 PM |
 | Cardiff Oncology to Participate in Gastrointestinal (GI) Oncology and Pancreatic Cancer Panel Discussion at the Cowen 41st Annual Health Care Conference finance.yahoo.com - February 24 at 12:48 PM |
|
 | Head to Head Analysis: Cardiff Oncology (NASDAQ:CRDF) & Mosaic ImmunoEngineering (OTCMKTS:CPMV) americanbankingnews.com - February 21 at 2:18 AM |
 | Cardiff Oncology (NASDAQ:CRDF) Stock Price Down 8.1% americanbankingnews.com - February 18 at 8:34 PM |
 | Cardiff Oncology (CRDF) May Report Negative Earnings: Know the Trend Ahead of Q4 Release msn.com - February 18 at 1:36 PM |
 | Cardiff Oncology to Present at the LifeSci Partners Precision Oncology Day finance.yahoo.com - February 16 at 2:52 PM |
 | Cardiff Oncology (NASDAQ:CRDF) Stock Price Down 8.5% americanbankingnews.com - February 12 at 8:18 PM |
 | Cardiff Oncology (NASDAQ:CRDF) Trading 9.5% Higher americanbankingnews.com - February 11 at 7:52 PM |
 | Cardiff Oncology Presents Phase 2 mCRPC Trial Data Showing a Two-Fold Increase in Efficacy with an Optimized Onvansertib Dosing Schedule finance.yahoo.com - February 11 at 12:37 PM |
 | Why Cardiff Oncology Ran Up 1,350% in 2020 msn.com - January 31 at 9:21 AM |
 | Why Cardiff Oncology Stock Is Crashing Today msn.com - January 15 at 12:47 PM |
 | Cardiff Oncology Presents Data that Continues to Demonstrate the Clinical Benefit of Onvansertib in KRAS-Mutated mCRC and Initial Findings from its Expanded Access Program finance.yahoo.com - January 15 at 12:47 PM |
 | Okyo Pharma Li. Regulatory News lse.co.uk - January 8 at 3:36 AM |
 | Labcorp Awarded CDC Contract to Study Variants of COVID-19 Virus and Improve Public Health Response finance.yahoo.com - January 7 at 5:34 PM |
 | Hudson Technologies Applauds Adoption of Omnibus/Covid-19 Relief Which Includes the Phasedown of HFC Production finance.yahoo.com - December 29 at 9:09 AM |
 | Cardiff Oncology Announces the Appointment of Dr. Rodney Markin as Chairman of the Board finance.yahoo.com - December 21 at 5:33 PM |
 | Walgreens and Labcorp Make Pixel by Labcorp™ At-Home COVID-19 Collection Kit Available Through Walgreens Find Care® finance.yahoo.com - December 21 at 7:23 AM |
 | Hedge Funds Have Never Been This Bullish On Cardiff Oncology (CRDF) finance.yahoo.com - December 16 at 3:22 PM |
 | LabCorp receives FDA authorization for at-home COVID-19 kits finance.yahoo.com - December 11 at 5:53 PM |
 | LabCorp Receives FDA Authorization to Make At-Home COVID-19 Collection Kits Available Through Retail finance.yahoo.com - December 9 at 6:19 PM |
 | Cardiff Oncology Presents Data at ASH Demonstrating the Safety and Anti-Leukemic Activity of Onvansertib in Patients with Relapsed/Refractory AML finance.yahoo.com - December 6 at 8:41 AM |
 | Cardiff Oncology: A Breakout Darkhorse In The Booming K-Ras Market seekingalpha.com - November 24 at 10:07 AM |
|
 | Cardiff Oncology to Participate in Fireside Chat at the Piper Sandler 32nd Annual Healthcare Conference finance.yahoo.com - November 23 at 9:49 AM |
 | Cardiff Oncology EPS in-line, beats on revenue seekingalpha.com - November 5 at 8:08 PM |
 | Cardiff Oncology Announces Third Quarter 2020 Results and Highlights finance.yahoo.com - November 5 at 8:08 PM |
 | Cardiff Oncology: A Solid Oncology Company With 50% Upside Potential seekingalpha.com - November 3 at 2:45 PM |
 | Have Insiders Been Buying Cardiff Oncology, Inc. (NASDAQ:CRDF) Shares? finance.yahoo.com - October 25 at 12:30 PM |
 | Why Cardiff Oncology's Stock Is Trading Higher Today benzinga.com - October 22 at 2:12 PM |
 | Hudson Technologies to Host Conference Call to Discuss Third Quarter 2020 Results finance.yahoo.com - October 22 at 9:11 AM |
 | Cardiff Oncology's onvansertib may overcome Zytiga resistance in prostate cancer seekingalpha.com - October 20 at 1:59 PM |
 | Cardiff Oncology Inc. barrons.com - October 17 at 10:55 PM |
 | Cardiff Oncology's Onvansertib Could Possibly End Up Being A Solid Cancer Drug seekingalpha.com - October 12 at 3:57 PM |
 | Why Cardiff Oncology Stock Skyrocketed Today fool.com - October 8 at 5:21 PM |
 | Cardiff Oncology Rakes In Over 200% Gain In 3 Months nasdaq.com - October 2 at 7:58 AM |
 | Thinking about trading options or stock in Alibaba, Cardiff Oncology, Penn National Gaming, Facebook, or Target? marketwatch.com - September 30 at 12:27 PM |
 | Cardiff Oncology prices equity offering at $13.50 seekingalpha.com - September 30 at 7:17 AM |
 | Cardiff Oncology readies equity offering seekingalpha.com - September 29 at 5:47 PM |
 | Cardiff Oncology +1% on KOL event on September 23 seekingalpha.com - September 17 at 11:15 PM |
 | Insider Buys Cardiff Oncology's Shares finance.yahoo.com - September 17 at 11:15 PM |
 | Cardiff Oncology's onvansertib shows sustained clinical benefit in colorectal cancer seekingalpha.com - September 17 at 11:15 PM |
 | Cardiff Oncology Presents Data at ESMO Confirming Efficacy of Onvansertib and Durability of Response in KRAS-Mutated Metastatic Colorectal Cancer (mCRC) finance.yahoo.com - September 17 at 8:13 AM |
 | Cardiff Oncology to Present Data Further Demonstrating the Safety and Efficacy of Onvansertib in KRAS-Mutated Metastatic Colorectal Cancer Patients finance.yahoo.com - September 14 at 9:25 AM |